Screening for prostate cancer using a blood test likely reduces the risk of dying from prostate cancer and may also reduce the risk of dying from any cause. Screening likely makes little to no ...
A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...
A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
Former President Joe Biden announced this weekend that he has been diagnosed with an aggressive form of prostate cancer, the second leading cause of cancer death for men in the United States. About 1 ...
A new study suggests that prostate cancer screening could reduce deaths by 13 per cent, as cancer experts in the UK assess ...
An updated Cochrane review has concluded there is evidence that PSA screening reduces prostate cancer deaths. The analysis of 800,000 men aged 50 to 74 years who took part in large trials across ...
The Independent on MSN
New blood test could show if prostate cancer treatment is failing
New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...
Novartis today announced new data from PSMAddition demonstrating improved prostate-specific antigen (PSA) responses with ...
This is a retrospective study of patients with metastatic Pca, diagnosed at King Hussein Cancer Center, Jordan, between 2006 and 2018. Survival was estimated using the Kaplan-Meier method and compared ...
A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results